Growth Metrics

Immunocore Holdings (IMCR) Cash from Investing Activities (2021 - 2025)

Historic Cash from Investing Activities for Immunocore Holdings (IMCR) over the last 5 years, with Q3 2025 value amounting to $5.3 million.

  • Immunocore Holdings' Cash from Investing Activities rose 73429.95% to $5.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$19.0 million, marking a year-over-year increase of 9460.85%. This contributed to the annual value of -$355.1 million for FY2024, which is 644615.67% down from last year.
  • According to the latest figures from Q3 2025, Immunocore Holdings' Cash from Investing Activities is $5.3 million, which was up 73429.95% from -$30.4 million recorded in Q2 2025.
  • Immunocore Holdings' 5-year Cash from Investing Activities high stood at $9.7 million for Q1 2025, and its period low was -$350.3 million during Q2 2024.
  • In the last 5 years, Immunocore Holdings' Cash from Investing Activities had a median value of -$985500.0 in 2021 and averaged -$27.1 million.
  • Per our database at Business Quant, Immunocore Holdings' Cash from Investing Activities tumbled by 2501333.33% in 2024 and then soared by 235627.91% in 2025.
  • Immunocore Holdings' Cash from Investing Activities (Quarter) stood at -$1.1 million in 2021, then plummeted by 80.05% to -$2.1 million in 2022, then surged by 60.3% to -$817000.0 in 2023, then crashed by 333.29% to -$3.5 million in 2024, then surged by 248.36% to $5.3 million in 2025.
  • Its Cash from Investing Activities was $5.3 million in Q3 2025, compared to -$30.4 million in Q2 2025 and $9.7 million in Q1 2025.